Fixed-schedule therapy
Showing 1 - 25 of >10,000
Efficacy of Fixed Dose Combination Therapy With Atorvastatin and
Enrolling by invitation
- Primary Hypercholesterolemia
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Nov 4, 2022
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Orthodontic Appliance Complication, Plaque, Dental, Gingival Inflammation Trial in Lund (Lumoral Treatment, Standard oral health
Not yet recruiting
- Orthodontic Appliance Complication
- +2 more
- Lumoral Treatment
- Standard oral health instructions
-
Lund, SwedenBorgska Villans Specialisttandvård
Apr 11, 2023
Fixed-schedule Benzodiazepine Dosing vs Based onCIWA-Ar Alcohol
Completed
- Alcoholdependence
- +2 more
- diazepam (or equivalence if other benzodiazepine)
- (no location specified)
Feb 25, 2021
Breast Cancer, Physical Activity Trial in Cleveland (Aerobic Training - Fixed Schedule, Resistance Training - Fixed Schedule,
Completed
- Breast Cancer
- Physical Activity
- Aerobic Training - Fixed Schedule
- +6 more
-
Cleveland, Ohio
- +2 more
Mar 21, 2022
Multiple Myeloma in Relapse Trial in Paris (Daratumumab/Lenalidomide/Dexamethasone for 24 months,
Recruiting
- Multiple Myeloma in Relapse
- Daratumumab/Lenalidomide/Dexamethasone for 24 months
- Daratumumab/Lenalidomide/Dexamethasone until progression
-
Paris, FranceSaint Antoine Hospital - Hematology Department
Jun 10, 2022
Malocclusion, Class II Malocclusion Trial in Hama (clear aligners, traditional treatment Fixed appliances with class II
Recruiting
- Malocclusion
- Class II Malocclusion
- clear aligners
- traditional treatment Fixed appliances with class II elastics.
-
Hama, Syrian Arab RepublicHama University
Jan 12, 2023
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Observational retrospective data collection
- (no location specified)
Dec 14, 2022
Pre-diabetes Trial in New York (Fixed Schedule)
Recruiting
- Pre-diabetes
- Fixed Schedule
-
New York, New YorkColumbia University Irving Medical Center
Sep 6, 2022
Invasive Breast Cancer, Post-mastectomy Trial in New York (Radiotherapy)
Recruiting
- Invasive Breast Cancer
- Post-mastectomy
- Radiotherapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022
Fixed LAMA/LABA/ICS Triple Therapy
Completed
- COPD
- Non-interventional
-
Liverpool, United KingdomLiverpool Heart and Chest Foundation Trust
Jul 20, 2022
Cytomegalovirus Retinitis, HIV Trial in United States (Ganciclovir)
Completed
- Cytomegalovirus Retinitis
- HIV Infections
-
Los Angeles, California
- +5 more
Oct 28, 2021
Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia
- Ibrutinib and obinutuzumab
-
Milano, MI, ItalyStrategic Research Program on CLL
Apr 2, 2022
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Beclometasone/Formoterol/Glycopyrronium DPI in Chronic
Not yet recruiting
- COPD
- Beclometasone/Formoterol/Glycopyrronium 88 µg/5 µg/9 µg DPI (Trimbow® 88 µg/5 µg/9 µg in NEXThaler device)
- (no location specified)
Jul 10, 2023
Thoracic Cancer, Pancreatic Cancer Non-resectable, Brain Cancer Trial (Proton Radiation)
Not yet recruiting
- Thoracic Cancer
- +4 more
- Proton Radiation
- (no location specified)
Sep 19, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Coronary Artery Diseasse Trial in Seoul (fixed high potent statin therapy, targeted LDL-C goal statin)
Active, not recruiting
- Coronary Artery Diseasse
- fixed high potent statin therapy
- targeted LDL-C goal statin
-
Seoul, Korea, Republic ofDivision of Cardiology, Department of Internal Medicine, Yonsei
Jul 19, 2022
Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy Trial in Toronto (Risperidone, Olanzapine)
Recruiting
- Schizophrenia and Related Disorders
- +3 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jul 20, 2022
Breast Cancer Female Trial in Kolkata (3 week RT, 1 week RT)
Recruiting
- Breast Cancer Female
- 3 week RT
- 1 week RT
-
Kolkata, West Bengal, IndiaSanjoy Chatterjee
Dec 2, 2021
Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)
Recruiting
- Multiple Myeloma
- TAA-specific CTLs
- TAA-specific CTLs- fixed dose
-
Houston, TexasHouston Methodist Hospital
Nov 11, 2022
Patients Treated With Telmisartan/Hydrochlorothiazide or
Withdrawn
- Hypertension
- subjects treated with telmisartan/hydrochlorothiazide
- +3 more
-
Tokyo, JapanNippon Boehringer Ingelheim Co., Ltd.
Jun 23, 2022
Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)
Not yet recruiting
- Multiple Myeloma
- +8 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Oct 13, 2022
Real-life: Impact on Adherence and Health Status (TRITRIAL)
Completed
- COPD
- BDP/FF/G fixed combination
-
Rome, ItalyFondazione Policlinico Gemelli
May 4, 2022
Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,
Completed
- Stable Angina
- +2 more
- 3-months DAPT
- 1-year DAPT
-
Busan, Korea, Republic of
- +11 more
Jan 8, 2023